Ramucirumab Drug Interactions
Currently displaying a list of 141 drugs known to interact with ramucirumab.
- 100 major drug interactions
- 41 moderate drug interactions
Medications known to interact with ramucirumab
Note: Showing generic names only.
A
- abciximab
- acalabrutinib
- ado-trastuzumab emtansine
- alteplase
- anagrelide
- anisindione
- anistreplase
- antithrombin (recombinant)
- antithrombin iii
- apixaban
- ardeparin
- argatroban
- aspirin
- avapritinib
B
C
- cabozantinib
- cangrelor
- caplacizumab
- choline salicylate
- cilostazol
- citalopram
- clomipramine
- clopidogrel
D
- dabigatran
- dalteparin
- danaparoid
- daprodustat
- dasatinib
- deferasirox
- defibrotide
- deoxycholic acid
- desirudin
- desvenlafaxine
- dexfenfluramine
- dextran 1
- dextran, high molecular weight
- dextran, low molecular weight
- diclofenac
- diclofenac ophthalmic
- diclofenac topical
- dicumarol
- diflunisal
- dimethyl fumarate
- dipyridamole
- diroximel fumarate
- drotrecogin alfa
- duloxetine
E
- edoxaban
- efgartigimod alfa
- encorafenib
- enoxaparin
- epoprostenol
- eptifibatide
- erlotinib
- escitalopram
- etodolac
F
- fedratinib
- fenfluramine
- fenoprofen
- fluoxetine
- flurbiprofen
- flurbiprofen ophthalmic
- fluvoxamine
- fondaparinux
H
I
K
L
M
N
O
P
- panobinostat
- paroxetine
- pentosan polysulfate sodium
- phenylbutazone
- piroxicam
- plicamycin
- ponatinib
- prasugrel
R
S
- salsalate
- sertraline
- sibutramine
- sodium salicylate
- sodium thiosalicylate
- streptokinase
- sulfinpyrazone
- sulindac
- suprofen ophthalmic
T
- tazemetostat
- tenecteplase
- ticagrelor
- ticlopidine
- tinzaparin
- tipranavir
- tirofiban
- tolmetin
- tositumomab
- tovorafenib
- treprostinil
U
V
W
Z
Ramucirumab disease interactions
There are 8 disease interactions with ramucirumab which include:
- bleeding
- GI perforation
- hypothyroidism
- liver dysfunction
- hypertension
- PRES
- proteinuria
- thromboembolic disorders
More about ramucirumab
- ramucirumab consumer information
- Check interactions
- Compare alternatives
- Side effects
- Dosage information
- During pregnancy
- Drug class: VEGF/VEGFR inhibitors
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.